A Pilot Randomized Controlled Trial to Reduce Salt Intake Among Hypertensive Young Adults in Hong Kong

NCT02920437 | Terminated

• 1 other identifier: UW 16-280
• Study Type: interventional
• Target: 19
• Locations: 1 country
• Sites: 1

Brief Summary

A pilot randomized controlled trial will be conducted to investigate the feasibility and effectiveness of a salt intake reduction intervention to young hypertension patients in Hong Kong who had high salt intake.

Conditions

Hypertension

Keywords

dietary salt; 24 hour urinary sodium excretion; blood pressure; hypertension

Outcome Measures

Primary Outcomes (1)

• 24-hour urinary sodium excretion

  Difference between the intervention and control group in the change in 24-hour urinary sodium excretion from baseline to the end of follow-up

  10-Week

Secondary Outcomes (1)

• Health literacy on low salt intake

  10-Week

Study Arms (2)

Intervention group

EXPERIMENTAL

Four-week weekly intervention to reduce salt intake.

Behavioral: Four-week weekly intervention to reduce salt intake

Control group

OTHER

Usual government pamphlets.

Other: Usual government pamphlets

Interventions

Four-week weekly intervention to reduce salt intake BEHAVIORAL

The intervention group will receive a four-week weekly intervention, about 15 minutes each. Two sessions will be face-to-face and two sessions will be on the phone. The participants will be informed of their 24-hour urinary sodium excretion at each measurement time once available.

Intervention group

Usual government pamphlets OTHER

The control group will receive usual government pamphlets when they know their 24-hour urinary sodium excretion at baseline. However, they will not be informed of their follow-up urinary sodium excretion results immediately.

Control group

Eligibility Criteria

• Age: 18 Years - 44 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• i) adults aged 18 to 44
• ii) diagnosed hypertension or borderline hypertension
• iii) complete collection of 24-hour urine at baseline
• iv) 24-hour urinary sodium excretion above 2000mg at baseline
• v) can communicate in Cantonese

You may not qualify if:

• i) renal illnesses;
• ii) taking diuretics;
• iii) taking RAS blockers;
• iv) attending or planning to attend new hypertension education programme or salt intake reduction programme during the study period.

Sponsors & Collaborators

• The University of Hong Kong: lead

Study Sites (1)

School of Nursing, The University of Hong Kong

Hong Kong, China

Location

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular Diseases; Cardiovascular Diseases

Study Officials

• Chau Pui Hing, PhD

  School of Nursing, The University of Hong Kong

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: September 29, 2016
• First Posted: September 30, 2016
• Study Start: October 1, 2016
• Primary Completion: October 1, 2017
• Study Completion: October 1, 2017
• Last Updated: April 18, 2019

Record last verified: 2019-04

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)